lobbying_activities: 2189922

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2189922	53f8389c-ce29-45ac-b76e-64371bc00b18	Q3	RUBICON ADVISORS, LLC	315091	DR. REDDY'S LABORATORIES, LTD	2018	third_quarter	PHA	Prescription Drug User Fee Act (PDUFA) reauthorization. Generic Drug User Fee Act (GDUFA) reauthorization. Border Adjustment Tax (BAT) issues	Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE	45000		0	0	2018-10-18T09:52:08.403000-04:00